These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 32283989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F, Schaefer F, Stuermer R, Boucsein W, Timmermann L, Barbe MT, Ebersbach G, Otto J, Kessler J, Kalbe E.
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The contribution of apathy and increased learning trials to risky decision-making in Parkinson's disease.
    Buelow MT, Frakey LL, Grace J, Friedman JH.
    Arch Clin Neuropsychol; 2014 Feb; 29(1):100-9. PubMed ID: 23969088
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Decision-making in Parkinson's disease patients with and without pathological gambling.
    Rossi M, Gerschcovich ER, de Achaval D, Perez-Lloret S, Cerquetti D, Cammarota A, Inés Nouzeilles M, Fahrer R, Merello M, Leiguarda R.
    Eur J Neurol; 2010 Jan; 17(1):97-102. PubMed ID: 19780806
    [Abstract] [Full Text] [Related]

  • 9. Pathological Gambling in Parkinson's disease: Autonomic measures supporting impaired decision-making.
    Angioletti L, Siri C, Meucci N, Pezzoli G, Balconi M.
    Eur J Neurosci; 2019 Aug; 50(3):2392-2400. PubMed ID: 29888425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.
    Gul A, Yousaf J.
    Singapore Med J; 2019 Aug; 60(8):414-417. PubMed ID: 30246215
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT, Georgiev D, Foltynie T, Limousin P, Speekenbrink M, Jahanshahi M.
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional neuroimaging of the Iowa Gambling Task in older adults.
    Halfmann K, Hedgcock W, Bechara A, Denburg NL.
    Neuropsychology; 2014 Nov; 28(6):870-80. PubMed ID: 25068669
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease.
    Manza P, Schwartz G, Masson M, Kann S, Volkow ND, Li CR, Leung HC.
    Neurobiol Aging; 2018 Jun; 66():12-22. PubMed ID: 29501966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.